Abstract:Background and objectives: Many cutaneous drug-delivery techniques rely on passive diffusion to deliver topical compounds to the skin. When attempting to deliver drugs to thicker lesions, such as skin tumors, modalities that do not rely on diffusion may serve as a better drug-delivery method. In this histological study, we aim to investigate the cutaneous delivery patterns of an electronic pneumatic needle-free injection device. Study design/materials and methods: Needle-free-injection was investigated in 24 ex vivo porcine skin samples and one basal cell carcinoma (BCC) tissue sample. A needle-free injection device with a nozzle size of 200 μm delivered 80 μl compound ink (0.1 cc black ink: 5.0 cc saline) at low (30%/3.1 bar; n = 6 porcine skin; n = 1 BCC tissue), medium (50%/3.9 bar; n = 6 porcine skin), high (65%/4.6 bar; n = 6 porcine skin), and stacked (30 + 50%/3.1 + 3.9 bar; n = 6 porcine skin) pressures. Depth, width, and depth of maximum width of ink deposition were evaluated on histological slides. Results: Depositions with small ink-lined vacuoles were seen intra-dermally in all samples, including the BCC tissue. Deposition depth was similar at low and medium pressures (924 vs. 994 μm; P = 0.873) but increased significantly with high pressure (1,564 μm; P = 0.010). When injections were stacked (3.1 + 3.9 bar), the depth remained similar to that of a single injection (931 μm; P = 1.000). The width of the deposition stayed comparable for low, medium, and high pressures when a single needle-free injection was performed (30% = 2,394 μm; 50% = 2,226 μm; and 65% = 2,757 μm; P = 0.09), but increased significantly with stacking (2,979 μm; P = 0.037). The depth of maximal width was superficially located in the papillary dermis at low and medium pressures (321 and 305 μm; P = 0.748) but shifted to the deeper reticular dermis with high pressure (950 μm; P = 0.004) and with stacking (734 μm; P = 0.004). Conclusions: In conclusion, with an electronically controlled, pneumatic needle-free injector, depth and width of a cutaneous deposition can be influenced by pressure and stacking, respectively. The pneumatic needle-free injection can potentially serve as a viable drug-delivery technique for cutaneous pathologies where dermal deposition is essential. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.

Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation.

Minimally invasive and targeted therapeutic cell delivery to the skin using microneedle devices

Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies

Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations

Cryomicroneedles for transdermal cell delivery

Application of laser-assisted transdermal drug delivery in dermatology

Laser Ablation-Enhanced Transdermal Drug Delivery

Localised light delivery on melanoma cells using optical microneedles

Microfabricated silicon microneedles for nonviral cutaneous gene delivery

Transdermal Delivery of siRNA through Microneedle Array

Efficient Delivery of Nucleic Acid Molecules into Skin by Combined Use of Microneedle Roller and Flexible Interdigitated Electroporation Array.

Microneedle assisted delivery of epidermal and dermal stem cells to promote hair growth

In Situ-Formed Cryomicroneedles for Intradermal Cell Delivery

Intradermal Delivery of Cell Vaccine via Ice Microneedles for Cancer Treatment

Laser-Induced Intracellular Delivery: Exploiting Gold-Coated Spiky Polymeric Nanoparticles and Gold Nanorods under Near-Infrared Pulses for Single-Cell Nano-Photon-Poration

Needle-Free Injection Assisted Drug Delivery-Histological Characterization of Cutaneous Deposition

An Optical Microneedle for Localized Light Therapy on Melanoma Cells

Optical Effects of Focused Fractional Nanosecond 1064‐nm Nd:YAG Laser: Techniques of Application on Human Skin

Evaluation of a Novel Ablative 1940 nm Pulsed Laser for Skin Rejuvenation

Microneedle mediated delivery of nanoparticles into human skin

Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma